Oral administration of a decaffeinated green tea (Camellia sinensis) extract did not alter urinary 8-epi-prostaglandin F2alpha, a biomarker for in-vivo lipid peroxidation

Authors: Donovan, Jennifer L.1; DeVane, C. Lindsay1; Chavin, Kenneth D.2; Oates, James C.3; Njoku, Chinedu3; Patrick, Kennerly S.4; Fiorini, Ryan N.2; Markowitz, John S.4

Source: Journal of Pharmacy and Pharmacology, Volume 57, Number 10, October 2005 , pp. 1365-1369(5)

Publisher: Pharmaceutical Press

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Oxidative stress is involved in the pathogenesis of numerous chronic human diseases. The objective of this study was to determine whether administration of a decaffeinated green tea extract providing 844 mg flavonoids daily reduced the urinary excretion of 8-epi-prostaglandin F2alpha (8-epi-PGF2alpha), a product of lipid peroxidation in cellular membranes and of low-density lipoprotein (LDL). Nine healthy male and female subjects were studied at baseline and after 14 days of green tea supplementation. Analysis of urinary 8-epi-PGF2alpha was performed using immunoaffinity extraction-gas chromatography-negative ion chemical ionization-mass spectrometry (GC-NICI-MS). Urinary 8-epi-PGF2alpha concentrations were 0.286±0.120 nmol (mmol creatinine)-1 at baseline and 0.244±0.177 nmol mmol-1 creatinine after green tea supplementation. There were no significant differences in the excretion of urinary 8-epi-PGF2alpha after treatment with green tea. We conclude that 14 days of green tea supplementation did not significantly alter in-vivo lipid peroxidation.

Document Type: Short communication

DOI: 10.1211/jpp.57.10.0017

Affiliations: 1: Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA 2: Department of Surgery, Division of Transplantation, Medical University of South Carolina, Charleston, South Carolina, USA 3: Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina, USA 4: Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA

Your trusted access to this article has expired.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$38.34 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A